1126366-52-6

Basic information

• Product Name: 4-[(4-ethoxypyridin-2-yl)methoxy]-N-[2-methyl-5-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide
• Synonyms: 4-[(4-ethoxypyridin-2-yl)methoxy]-N-[2-methyl-5-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide
• CAS NO: 1126366-52-6
• Molecular Weight: 442.517
• Mol File: 1126366-52-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[(4-ethoxypyridin-2-yl)methoxy]-N-[2-methyl-5-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(4-ethoxypyridin-2-yl)methoxy]-N-[2-methyl-5-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide(1126366-52-6)
• EPA Substance Registry System: 4-[(4-ethoxypyridin-2-yl)methoxy]-N-[2-methyl-5-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide(1126366-52-6)

Safety Data

• Hazardous Substances Data: 1126366-52-6(Hazardous Substances Data)

Upstream product

• 1126369-75-2 4-hydroxy-N-(2-methyl-5-(1-methyl-1H-imidazol-2-yl)phenyl)benzamide 
• 159996-13-1 2-(chloromethyl)-4-ethoxypyridine 

Relevant articles and documents

HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS

The present disclosure relates to heterocyclic amide compounds, which are useful for inhibiting the Hedgehog pathway, and their use in treating a disease or medical condition mediated alone or in part by Hedgehog pathway inhibition. Also disclosed are methods for manufacture of these compounds, pharmaceutical compositions including these compounds, and use of these compounds in the manufacture of medicaments for treating such diseases and medical conditions in a subject. Formula (IA) with the provisio that either R2or R3 is (Z).